5,378 Shares in HCA Healthcare, Inc. $HCA Acquired by Atlas Capital Advisors Inc.

Atlas Capital Advisors Inc. bought a new position in shares of HCA Healthcare, Inc. (NYSE:HCAFree Report) during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm bought 5,378 shares of the company’s stock, valued at approximately $2,511,000.

Other hedge funds have also added to or reduced their stakes in the company. Aptus Capital Advisors LLC lifted its position in shares of HCA Healthcare by 5.6% during the 4th quarter. Aptus Capital Advisors LLC now owns 3,231 shares of the company’s stock valued at $1,508,000 after acquiring an additional 170 shares during the period. Arete Wealth Advisors LLC acquired a new position in shares of HCA Healthcare during the 4th quarter valued at $269,000. Templeton & Phillips Capital Management LLC acquired a new position in shares of HCA Healthcare during the 4th quarter valued at $211,000. Transamerica Financial Advisors LLC lifted its position in shares of HCA Healthcare by 131.6% during the 4th quarter. Transamerica Financial Advisors LLC now owns 183 shares of the company’s stock valued at $85,000 after acquiring an additional 104 shares during the period. Finally, Parkside Financial Bank & Trust raised its holdings in HCA Healthcare by 21.7% during the fourth quarter. Parkside Financial Bank & Trust now owns 1,449 shares of the company’s stock worth $676,000 after buying an additional 258 shares during the last quarter. 62.73% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several research firms have weighed in on HCA. Oppenheimer lowered their price objective on shares of HCA Healthcare from $540.00 to $520.00 and set an “outperform” rating on the stock in a report on Monday, April 27th. Wall Street Zen downgraded shares of HCA Healthcare from a “buy” rating to a “hold” rating in a report on Saturday, May 2nd. Robert W. Baird lowered their price objective on shares of HCA Healthcare from $450.00 to $442.00 and set a “neutral” rating on the stock in a report on Wednesday, April 15th. KeyCorp lowered their target price on shares of HCA Healthcare from $550.00 to $510.00 and set an “overweight” rating for the company in a report on Monday, April 27th. Finally, Barclays lowered their target price on shares of HCA Healthcare from $551.00 to $496.00 and set an “overweight” rating for the company in a report on Monday, April 27th. Fifteen research analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of $506.14.

Check Out Our Latest Analysis on HCA

HCA Healthcare Stock Up 2.3%

HCA opened at $387.25 on Friday. The company has a market capitalization of $85.91 billion, a price-to-earnings ratio of 13.32, a PEG ratio of 1.23 and a beta of 1.12. The firm has a 50-day moving average price of $429.60 and a 200-day moving average price of $473.48. HCA Healthcare, Inc. has a twelve month low of $330.00 and a twelve month high of $556.52.

HCA Healthcare (NYSE:HCAGet Free Report) last posted its earnings results on Friday, April 24th. The company reported $7.15 earnings per share for the quarter, missing the consensus estimate of $7.19 by ($0.04). HCA Healthcare had a negative return on equity of 295.93% and a net margin of 8.89%.The business had revenue of $19.11 billion during the quarter, compared to analysts’ expectations of $19.09 billion. During the same quarter in the previous year, the business earned $6.45 EPS. HCA Healthcare’s revenue for the quarter was up 4.3% on a year-over-year basis. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. On average, sell-side analysts expect that HCA Healthcare, Inc. will post 30.07 earnings per share for the current fiscal year.

HCA Healthcare Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Tuesday, June 30th. Shareholders of record on Tuesday, June 16th will be given a dividend of $0.78 per share. The ex-dividend date is Tuesday, June 16th. This represents a $3.12 annualized dividend and a yield of 0.8%. HCA Healthcare’s payout ratio is presently 10.73%.

About HCA Healthcare

(Free Report)

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.

See Also

Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCAFree Report).

Institutional Ownership by Quarter for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.